Boston, September 9, 2024 – OmniZare Imaging, an innovative new technology company applying its expertise to revolutionize medical imaging, today announced that Drs. William Chin and Edward Legare have joined its Medical Advisory Board. Co-founded by Eric Giler and Dr. Andre Kurs, OmniZare aims to democratize high-quality medical imaging, improve medical outcomes, and reduce mortality by facilitating early diagnosis and detection of treatable conditions.

OmniZare has developed an imaging platform consisting of: purpose-built sensing hardware; and cloud software to analyze and interpret the data. The company uses Dielectric Tomography which produces three-dimensional millimeter-scale resolution of the ultra- wideband dielectric and magnetic properties of biological tissue. To-date, the company has developed:

Cranial scanner to diagnose and screen for stroke, tumors, and traumatic brain injury
Handheld scanner for liver conditions and traumatic injuries
Extremity scanner to monitor and manage age-related muscle and bone diseases
Breast imaging capabilities

“OmniZare has assembled a leadership team with deep expertise and a proven track record in management, technology, product development, and intellectual property strategy. Bill and Ned bring their valuable medical opinions and experience to the team,” said Eric Giler, Co-Founder of OmniZare. “Bill has tremendous industry experience and deep knowledge of medicine . Ned brings his patient connections and understanding of the struggle patients face when trying to get a proper imaging diagnosis quickly and affordably.”

Dr. William Chin is the Bertarelli Professor of Translational Medical Science and Medicine Emeritus, Harvard Medical School (HMS) and a former executive leader in pharmaceutical R&D. He is a former Senior Vice President and Head of Global Research at Eli Lilly and Company; and Executive Vice President and Chief, Medical Officer, PhRMA

He has also served as: Executive Dean for Research, HMS; Chief of the Division of Genetics, Brigham and Women’s Hospital and HMS; and Investigator, Howard Hughes Medical Institute. Dr. Chin is a world-renowned scientist who has performed basic science research in the hormonal regulation of gene expression. Dr. Chin received his AB in Chemistry from Columbia University, and holds a MD from Harvard Medical School and is Board-certified in Internal Medicine and Endocrinology.

“OmniZare’s technology is a game-changer in the world of medical imaging,” explained Dr. Chin. “By radically reducing cost and form factor, the company will help to revolutionize the ways we use imaging at the point of care, in emergencies, and throughout the developing world.”

Most Read Announcements Homepage